These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35608271)

  • 1. Characterizing the metabolic role of STAT3 in canine osteosarcoma.
    Gardner HL; Fenger JM; Roberts RD; London CA
    Vet Comp Oncol; 2022 Dec; 20(4):817-824. PubMed ID: 35608271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines.
    Couto JI; Bear MD; Lin J; Pennel M; Kulp SK; Kisseberth WC; London CA
    BMC Vet Res; 2012 Dec; 8():244. PubMed ID: 23244668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
    Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
    BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.
    Fossey SL; Bear MD; Lin J; Li C; Schwartz EB; Li PK; Fuchs JR; Fenger J; Kisseberth WC; London CA
    BMC Cancer; 2011 Mar; 11():112. PubMed ID: 21443800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
    Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
    BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
    Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
    Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Zhangfei/CREBZF on cell growth, differentiation, apoptosis, migration, and the unfolded protein response in several canine osteosarcoma cell lines.
    Zhang R; Thamm DH; Misra V
    BMC Vet Res; 2015 Feb; 11():22. PubMed ID: 25890299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
    Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
    Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro.
    Holmes KE; Thompson V; Piskun CM; Kohnken RA; Huelsmeyer MK; Fan TM; Stein TJ
    Vet Comp Oncol; 2015 Sep; 13(3):166-75. PubMed ID: 23489774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
    Wang YT; Tang F; Hu X; Zheng CX; Gong TJ; Zhou Y; Luo Y; Min L
    IUBMB Life; 2020 Oct; 72(10):2146-2153. PubMed ID: 33448097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenine 3-monooxygenase (KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survival in canine melanoma.
    Liu IL; Chung TF; Huang WH; Hsu CH; Liu CC; Chiu YH; Huang KC; Liao AT; Lin CS
    Vet Comp Oncol; 2021 Mar; 19(1):79-91. PubMed ID: 32720434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-tumorigenic effects of transforming growth factor beta 1 in canine osteosarcoma.
    Portela RF; Fadl-Alla BA; Pondenis HC; Byrum ML; Garrett LD; Wycislo KL; Borst LB; Fan TM
    J Vet Intern Med; 2014; 28(3):894-904. PubMed ID: 24684686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
    Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
    J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma.
    Neumann ZL; Pondenis HC; Masyr A; Byrum ML; Wycislo KL; Fan TM
    J Vet Intern Med; 2015; 29(6):1584-94. PubMed ID: 26426813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
    Mao M; Zhang T; Wang Z; Wang H; Xu J; Yin F; Wang G; Sun M; Wang Z; Hua Y; Cai Z
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1214-1225. PubMed ID: 30659925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
    Fenger JM; London CA; Kisseberth WC
    ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM59 promotes osteosarcoma progression via activation of STAT3.
    Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
    Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
    York D; Withers SS; Watson KD; Seo KW; Rebhun RB
    Vet Comp Oncol; 2017 Sep; 15(3):1087-1100. PubMed ID: 27333821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.